Analystreport

Ligand Pharmaceuticals Inc. (NASDAQ: LGND) was downgraded by analysts at Cantor Fitzgerald from an "overweight" rating to a "neutral" rating.

Ligand Pharmaceuticals Incorporated  (LGND) 
Last ligand pharmaceuticals incorporated earnings: 2/6 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.ligand.com